Mdxhealth Sa Share Price (NASDAQ: MDXH)

$3.54

▲

0.08

(2.31%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Mdxhealth Sa Stock chart to analyse performance

Mdxhealth Sa stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$3.48
Today's High:$3.65
$3.54
1.84%
Downside
Day's Volatility :4.79%
Upside
3.01%
52 Weeks Low:$1.35
52 Weeks High:$3.81
$3.54
61.86%
Downside
52 Weeks Volatility :64.57%
Upside
7.09%

Mdxhealth Sa Stock Returns

Period	Mdxhealth Sa	Sector (Health Care)	Index (Russel 2000)
3 Months	60.68%	3.6%	0.0%
6 Months	106.73%	-7.7%	0.0%
1 Year	21.48%	-12.6%	0.0%
3 Years	-54.74%	9.5%	-4.7%

Mdxhealth Sa Key Stats

Check Mdxhealth Sa key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$3.46
Open	$3.59
Today's High	$3.65
Today's Low	$3.475
Market Capitalization	$171.3M
Today's Volume	$225.5K
52 Week High	$3.81
52 Week Low	$1.35
Revenue TTM	$99.0M
EBITDA	$-11.2M
Earnings Per Share (EPS)	$-0.76
Profit Margin	-34.98%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-1552.23%

Stock Returns calculator for Mdxhealth Sa Stock including INR - Dollar returns

The Mdxhealth Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Mdxhealth Sa investment value today

Current value as on today

₹1,26,517

Returns

₹26,517

(+26.52%)

Returns from Mdxhealth Sa Stock

₹21,233 (+21.23%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Mdxhealth Sa Stock

-17%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Mdxhealth Sa Stock from India on INDmoney has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Mdxhealth Sa

Name
Holdings %

Analyst Recommendation on Mdxhealth Sa Stock

Rating

Trend

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Mdxhealth Sa(by analysts ranked 0 to 5 stars)

Mdxhealth Sa Share Price Target

What analysts predicted

Upside of 70.62%

Target:

$6.04

Current:

$3.54

Mdxhealth Sa share price target is $6.04, a slight Upside of 70.62% compared to current price of $3.54 as per analysts' prediction.

Mdxhealth Sa Stock Insights

Price Movement
In the last 7 days, MDXH stock has moved up by 7.4%
Increasing Revenue
Revenue is up for the last 2 quarters, 24.29M → 26.60M (in $), with an average increase of 8.7% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -9.20M → -7.37M (in $), with an average increase of 24.9% per quarter
MDXH vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 34.2% return, outperforming this stock by 12.9%
MDXH vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 85.1% return, outperforming this stock by 142.5%
Price to Sales
ForMDXH every $1 of sales, investors are willing to pay $1.6, whereas for Idexx Laboratories, Inc., the investors are paying $13.0 for every $1 of sales.

Mdxhealth Sa Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$11.8M	↓ 58.41%
Net Income	$-43.1M	↑ 32.82%
Net Profit Margin	-365.72%	↓ 251.21%

	FY20	Y/Y Change
Revenue	$18.4M	↑ 55.89%
Net Income	$-30.0M	↓ 30.38%
Net Profit Margin	-163.33%	↑ 202.39%

	FY21	Y/Y Change
Revenue	$22.2M	↑ 21.05%
Net Income	$-30.9M	↑ 2.9%
Net Profit Margin	-138.84%	↑ 24.49%

	FY22	Y/Y Change
Revenue	$37.1M	↑ 66.62%
Net Income	$-50.2M	↑ 62.54%
Net Profit Margin	-135.45%	↑ 3.39%

	FY23	Y/Y Change
Revenue	$70.2M	↑ 89.43%
Net Income	$-43.1M	↓ 14.12%
Net Profit Margin	-61.4%	↑ 74.05%

	FY24	Y/Y Change
Revenue	$90.0M	↑ 28.29%
Net Income	$-38.1M	↓ 11.67%
Net Profit Margin	-42.28%	↑ 19.12%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$19.8M	↑ 2.25%
Net Income	$-8.5M	↓ 20.61%
Net Profit Margin	-42.91%	↑ 12.35%

	Q2 FY24	Q/Q Change
Revenue	$22.2M	↑ 11.72%
Net Income	$-11.5M	↑ 35.45%
Net Profit Margin	-52.02%	↓ 9.11%

	Q3 FY24	Q/Q Change
Revenue	$23.3M	↑ 5.23%
Net Income	$-11.2M	↓ 2.94%
Net Profit Margin	-47.99%	↑ 4.03%

	Q4 FY24	Q/Q Change
Revenue	$24.7M	↑ 6.1%
Net Income	$-6.8M	↓ 38.86%
Net Profit Margin	-27.65%	↑ 20.34%

	Q1 FY25	Q/Q Change
Revenue	$24.3M	↓ 1.81%
Net Income	$-9.2M	↑ 34.61%
Net Profit Margin	-37.91%	↓ 10.26%

	Q2 FY25	Q/Q Change
Revenue	$26.6M	↑ 9.52%
Net Income	$-7.4M	↓ 19.95%
Net Profit Margin	-27.71%	↑ 10.2%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$-144.0K	↓ 100.86%

	FY20	Y/Y Change
Profit	$7.8M	↓ 5550.69%

	FY21	Y/Y Change
Profit	$10.4M	↑ 32.65%

	FY22	Y/Y Change
Profit	$19.2M	↑ 84.59%

	FY23	Y/Y Change
Profit	$43.9M	↑ 128.57%

	FY24	Y/Y Change
Profit	$55.1M	↑ 25.52%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$10.9M	↓ 13.68%

	Q2 FY24	Q/Q Change
Profit	$13.3M	↑ 21.47%

	Q3 FY24	Q/Q Change
Profit	$14.3M	↑ 7.44%

	Q4 FY24	Q/Q Change
Profit	$15.5M	↑ 8.7%

	Q1 FY25	Q/Q Change
Profit	$15.5M	↓ 0.08%

	Q2 FY25	Q/Q Change
Profit	$17.6M	↑ 13.31%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-22.3M	↓ 21.91%
Investing Cash Flow	$-73.0K	↓ 94.57%
Financing Cash Flow	$18.0M	↓ 56.89%

	FY20	Y/Y Change
Operating Cash Flow	$-20.2M	↓ 9.17%
Investing Cash Flow	$-537.0K	↑ 635.62%
Financing Cash Flow	$14.3M	↓ 20.46%

	FY21	Y/Y Change
Operating Cash Flow	$-22.5M	↑ 11.38%
Investing Cash Flow	$-885.0K	↑ 64.8%
Financing Cash Flow	$66.5M	↑ 365.35%

	FY22	Y/Y Change
Operating Cash Flow	$-34.1M	↑ 51.31%
Investing Cash Flow	$-29.2M	↑ 3195.25%
Financing Cash Flow	$20.8M	↓ 68.66%

	FY23	Y/Y Change
Operating Cash Flow	$-21.5M	↓ 36.99%
Investing Cash Flow	$-3.9M	↓ 86.52%
Financing Cash Flow	$32.3M	↑ 54.89%

	FY24	Y/Y Change
Operating Cash Flow	$-18.5M	↓ 13.8%
Investing Cash Flow	$-1.6M	↓ 58.38%
Financing Cash Flow	$44.6M	↑ 38.16%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-6.3M	↓ 18.52%
Investing Cash Flow	$-764.0K	-
Financing Cash Flow	$-805.0K	↓ 54.99%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-4.3M	↓ 32.27%
Investing Cash Flow	$-776.0K	↑ 1.57%
Financing Cash Flow	$11.9M	↓ 1579.75%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-5.6M	↑ 31.35%
Investing Cash Flow	$-13.0K	↓ 98.32%
Financing Cash Flow	$33.6M	↑ 181.68%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-3.1M	↓ 44.51%
Investing Cash Flow	$-229.0K	↑ 1661.54%
Financing Cash Flow	$884.0K	↓ 97.37%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-4.1M	↑ 31.56%
Investing Cash Flow	$-476.0K	↑ 107.86%
Financing Cash Flow	$23.4M	↑ 2552.15%

Mdxhealth Sa Technicals Summary

Sell

Neutral

Buy

Mdxhealth Sa is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Mdxhealth Sa Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Mdxhealth Sa	47.91%	106.73%	21.48%	-54.74%	-70.54%
Agilent Technologies Inc.	9.48%	-0.51%	-9.55%	-2.51%	24.3%
Idexx Laboratories, Inc.	20.87%	47.74%	37.7%	84.56%	62.07%
Thermo Fisher Scientific, Inc.	5.33%	-5.93%	-18.77%	-10.56%	13.57%
Danaher Corp.	4.43%	0.1%	-22.08%	-24.82%	-1.19%
Iqvia Holdings Inc.	2.55%	3.11%	-23.4%	-9.93%	15.42%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Mdxhealth Sa	NA	NA	NA	-0.47	-15.52	-0.08	NA	-0.02
Agilent Technologies Inc.	29.29	29.29	1.84	5.57	0.2	0.08	0.0	22.46
Idexx Laboratories, Inc.	53.78	53.78	4.84	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.33	28.33	1.99	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	43.68	43.68	2.06	7.77	0.07	0.04	0.01	73.1
Iqvia Holdings Inc.	27.61	27.61	1.08	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Mdxhealth Sa	Buy	$171.3M	-70.54%	NA	-34.98%
Agilent Technologies Inc.	Buy	$35.7B	24.3%	29.29	17.97%
Idexx Laboratories, Inc.	Buy	$51.8B	62.07%	53.78	24.41%
Thermo Fisher Scientific, Inc.	Buy	$184.9B	13.57%	28.33	15.24%
Danaher Corp.	Buy	$147.0B	-1.19%	43.68	14.21%
Iqvia Holdings Inc.	Buy	$32.4B	15.42%	27.61	7.88%

About Mdxhealth Sa

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. It also offers genomic prostate score, which provides personalized genomic insights to physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. The company sells its products through urology sales force consisting of direct sales representatives, strategic account managers, and regional sales managers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Organization	Mdxhealth Sa
Employees	312
CEO	Mr. Michael K. McGarrity
Industry	Healthcare

Key Management of Mdxhealth Sa

Name	Title
Mr. Michael K. McGarrity	CEO & Executive Director
Mr. Joseph Sollee J.D., LLM	Executive VP of Corporate Development & General Counsel
Mr. John A. Bellano	Chief Commercial Officer
Ms. Miriam Reyes	Executive Vice President of Operations
Mr. Scott McMahan	Vice President of Finance and Accounting

Important FAQs about investing in MDXH Stock from India :

What is Mdxhealth Sa share price today?

Mdxhealth Sa share price today is $3.54 as on August 30, 2025 at 1:29 am IST at the close of the market. Mdxhealth Sa share today touched a day high of $3.65 and a low of $3.48.

What is the 52 week high and 52 week low for Mdxhealth Sa share?

Mdxhealth Sa share touched a 52 week high of $3.81 and a 52 week low of $1.35. Mdxhealth Sa stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $3.54, lower by 7.09% versus the 52 week high.

How to invest in Mdxhealth Sa Stock (MDXH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Mdxhealth Sa on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mdxhealth Sa Shares that will get you 0.4237 shares as per Mdxhealth Sa share price of $3.54 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Mdxhealth Sa Stock (MDXH) from India?

Indian investors can start investing in Mdxhealth Sa (MDXH) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Mdxhealth Sa stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Mdxhealth Sa share’s latest price of $3.54 as on August 30, 2025 at 1:29 am IST, you will get 2.8249 shares of Mdxhealth Sa. Learn more about fractional shares .

What are the returns that Mdxhealth Sa has given to Indian investors in the last 5 years?

Mdxhealth Sa stock has given -70.54% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?